AMPLI Stock Overview
Designs, develops, and markets products for orthopedic surgery in France and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Amplitude Surgical SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.14 |
| 52 Week High | €3.58 |
| 52 Week Low | €2.70 |
| Beta | 0.49 |
| 11 Month Change | -1.26% |
| 3 Month Change | 0.64% |
| 1 Year Change | -2.48% |
| 33 Year Change | 49.52% |
| 5 Year Change | 111.45% |
| Change since IPO | -37.20% |
Recent News & Updates
Amplitude Surgical SA's (EPA:AMPLI) Popularity With Investors Is Clear
Sep 19
Investors Will Want Amplitude Surgical's (EPA:AMPLI) Growth In ROCE To Persist
May 22Shareholder Returns
| AMPLI | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | 0% | -1.1% | -2.1% |
| 1Y | -2.5% | 26.4% | -2.1% |
Return vs Industry: AMPLI underperformed the French Medical Equipment industry which returned 26.2% over the past year.
Return vs Market: AMPLI matched the French Market which returned -1.9% over the past year.
Price Volatility
| AMPLI volatility | |
|---|---|
| AMPLI Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 6.0% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.3% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: AMPLI has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: AMPLI's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 389 | Olivier Jallabert | www.amplitude-surgical.com |
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.
Amplitude Surgical SA Fundamentals Summary
| AMPLI fundamental statistics | |
|---|---|
| Market cap | €150.63m |
| Earnings (TTM) | €1.53m |
| Revenue (TTM) | €106.02m |
98.6x
P/E Ratio1.4x
P/S RatioIs AMPLI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMPLI income statement (TTM) | |
|---|---|
| Revenue | €106.02m |
| Cost of Revenue | €51.77m |
| Gross Profit | €54.25m |
| Other Expenses | €52.72m |
| Earnings | €1.53m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.032 |
| Gross Margin | 51.17% |
| Net Profit Margin | 1.44% |
| Debt/Equity Ratio | 110.9% |
How did AMPLI perform over the long term?
See historical performance and comparison